Evidence map›Paper›PMID 27065471›Full record

ArticleDementia and geriatric cognitive disorders extra

Consumption of Drugs and Nonpharmacological Therapies in Caregivers of Patients with Alzheimer's Disease: A Case-Control Study in Madrid.

Raquel Martín-García, Guillermo Martín-Avila, María De la Rubia-Marcos, Raquel Maroto-Rodríguez, Celia Ortega-Angulo, María Teresa Carreras Rodriguez, Francisco Abad Santos, Ana Beatriz Gago Veiga

Open access · goldAbstract read
In one paragraph

Article in Dementia and geriatric cognitive disorders extra. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Trial
  2. Article
  3. Trend in Respite Use by Race Among Caregivers for People Living With Dementia.The journals of gerontology. Series A, Biological sciences and medical sciences · 2024
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Raquel Martín-GarcíaUniversidad Autónoma de Madrid, Madrid, Spain.
Guillermo Martín-AvilaUniversidad Autónoma de Madrid, Madrid, Spain.
María De la Rubia-MarcosUniversidad Autónoma de Madrid, Madrid, Spain.
Raquel Maroto-RodríguezUniversidad Autónoma de Madrid, Madrid, Spain.
Celia Ortega-AnguloUniversidad Autónoma de Madrid, Madrid, Spain.
María Teresa Carreras RodriguezAlzheimer's Disease and Other Cognitive Disorders Unit, Department of Neurology, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa (IP), Madrid, Spain.
Francisco Abad SantosClinical Pharmacology Service, Hospital Universitario de la Princesa, Instituto Teófilo Hernando, Instituto de Investigación Sanitaria Princesa (IP), Madrid, Spain.
Ana Beatriz Gago VeigaAlzheimer's Disease and Other Cognitive Disorders Unit, Department of Neurology, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa (IP), Madrid, Spain.
Universidad Autónoma de Madrid · ESHospital Universitario de La Princesa · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDementia is a neurodegenerative disease whose prevalence is rising, and the need for assistance to patients becomes indispensable. The different types of dementia and their treatments have been widely studied; however, the health status of caregivers also requires our attention.

objectiveThe aim of our research was to evaluate whether caregivers of patients with dementia consume more medications than the general population, indicating underlying pathologies.

methodsA total of 91 caregivers of dementia patients were interviewed and their answers were compared with those from a control group of 48 people, taking into account demographic data, characteristics of patients and caregivers, pharmacological and nonpharmacological treatments and burden.

resultsCaregivers showed a significantly higher consumption of anxiolytics, antidepressants and antiplatelets (22.3, 13.2 and 11%, respectively) than the control group (14.6, 0 and 0%, respectively). Moreover, 45.1% of the caregivers used nonpharmacological therapies compared with 6.2% of the control group. There was a tendency to take more medications in those caregivers suffering from burden and those who had to take care of patients with behavioral changes.

conclusionCaregivers of dementia patients need more pharmacological and nonpharmacological therapies. They are a risk group that needs better care from the health system.

Indexed as

BurdenCaregiversDementiaTreatment

Identifiers

PMID27065471
PMCPMC4821148
OpenAlexW2315853461

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.